These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 11762099)

  • 1. Linezolid: a new antibiotic for gram-positive infections.
    Wilson P
    Hosp Med; 2001 Nov; 62(11):682-6. PubMed ID: 11762099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Linezolid, the first oxazolidinone antibiotic].
    Dutronc H; Bocquentin F; Galpérine T; Lafarie-Castet S; Dupon M
    Med Mal Infect; 2005 Sep; 35(9):427-34. PubMed ID: 16297585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of linezolid in the treatment of complicated skin and soft tissue infections.
    Peppard WJ; Weigelt JA
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):357-66. PubMed ID: 16771613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summaries for patients. Linezolid.
    Ann Intern Med; 2003 Jan; 138(2):I44. PubMed ID: 12529109
    [No Abstract]   [Full Text] [Related]  

  • 5. [Action in nosocomial pneumonia and severe skin and soft tissue infections. Linezolid in treatment].
    Bodmann KF
    Pharm Unserer Zeit; 2004; 33(1):38-41. PubMed ID: 14968711
    [No Abstract]   [Full Text] [Related]  

  • 6. [Linezolid, an agent from a new class of antibiotics].
    Kuijper EJ; Schippers EF; Bernards AT
    Ned Tijdschr Geneeskd; 2004 Aug; 148(32):1577-81. PubMed ID: 15382556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linezolid: its role in the treatment of gram-positive, drug-resistant bacterial infections.
    Ament PW; Jamshed N; Horne JP
    Am Fam Physician; 2002 Feb; 65(4):663-70. PubMed ID: 11871684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France.
    De Cock E; Sorensen S; Levrat F; Besnier JM; Dupon M; Guery B; Duttagupta S
    Med Mal Infect; 2009 May; 39(5):330-40. PubMed ID: 19304423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.
    Cepeda JA; Whitehouse T; Cooper B; Hails J; Jones K; Kwaku F; Taylor L; Hayman S; Shaw S; Kibbler C; Shulman R; Singer M; Wilson AP
    J Antimicrob Chemother; 2004 Feb; 53(2):345-55. PubMed ID: 14711840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging therapies for serious gram-positive bacterial infections: a focus on linezolid.
    Plouffe JF
    Clin Infect Dis; 2000 Sep; 31 Suppl 4():S144-9. PubMed ID: 11017864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Linezolid--novel antibiotic for the treatment of gram-positive bacterial infections].
    Jankowski A; Stefanik W
    Wiad Lek; 2006; 59(9-10):727-31. PubMed ID: 17338140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The first clinical experiences in Hungary with a new effective antibiotic (linezolid) effective against Gram-positive infections].
    Pulay I; Konkoly TM; Zsirka KA; Csapó Z; Flautner L; Tihanyi T
    Orv Hetil; 2003 Jan; 144(1):29-33. PubMed ID: 12635350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linezolid.
    French G
    Int J Clin Pract; 2001; 55(1):59-63. PubMed ID: 11219321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinupristin/dalfopristin and linezolid: spectrum of activity and potential roles in therapy--a status report.
    Batts DH; Lavin BS; Eliopoulos GM
    Curr Clin Top Infect Dis; 2001; 21():227-51. PubMed ID: 11572153
    [No Abstract]   [Full Text] [Related]  

  • 15. Linezolid for the treatment of serious gram-positive infections.
    McAuley L
    Issues Emerg Health Technol; 2001 Mar; (15):1-6. PubMed ID: 11902223
    [No Abstract]   [Full Text] [Related]  

  • 16. [Linezolid: antibacterial activity, clinical efficacy and resistance].
    Bourgeois-Nicolaos N; Piriou O; Butel MJ; Doucet-Populaire F
    Ann Biol Clin (Paris); 2006; 64(6):549-64. PubMed ID: 17162258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of linezolid in children: an overview of recent advances.
    Velissariou IM
    Expert Rev Anti Infect Ther; 2006 Dec; 4(6):947-52. PubMed ID: 17181410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and tolerability of linezolid therapy in the treatment of orthopedic implant infections caused by gram-positive multiresistant cocci].
    Jover-Diaz F; Talents A; Alcalá-Santaella R; Cuadrado JM; Olmedo N; Gazquez C
    Rev Clin Esp; 2010 Mar; 210(3):145-6. PubMed ID: 20167313
    [No Abstract]   [Full Text] [Related]  

  • 19. Linezolid for the treatment of adults with bone and joint infections.
    Falagas ME; Siempos II; Papagelopoulos PJ; Vardakas KZ
    Int J Antimicrob Agents; 2007 Mar; 29(3):233-9. PubMed ID: 17204407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linezolid: new preparation. In severe gram-positive infections.
    Prescrire Int; 2003 Apr; 12(64):46-8. PubMed ID: 12669726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.